Adam Levy
Patrimonio netto: 56 628 $ in data 31/08/2026
Patrimonio netto: 56 628 $ in data 31/08/2026
Adam S.
Levy is Director at Praxis Bioresearch LLC since 2023.
Mr. Levy is Chief Financial Officer & Secretary at Mineralys Therapeutics, Inc. since 2024.
Former roles include Chief Business Officer at Vical, Inc., Vice President-Healthcare Investment Banking at Wedbush Securities, Inc. from 2009 to 2011, Chief Business Officer at Brickell Subsidiary, Inc. from 2019 to 2020, Chief Financial Officer at Sanifit Therapeutics SA, Senior Vice President at Merrill Lynch, Pierce, Fenner & Smith, Inc. from 2013 to 2016, Chief Business Officer at Fresh Tracks Therapeutics, Inc., and Chief Business Officer at Viridian Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate studies at Cornell University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/03/2026 | 2.206 ( 0% ) | 56 628 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/03/2022 |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Direttore/Membro del Consiglio | 19/09/2023 |
| Società | Posizione | Fine |
|---|---|---|
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Direttore Finanziario/CFO | 01/01/2022 |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Corporate Officer/Principal | 01/01/2020 |
| VIRIDIAN THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/05/2016 |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01/04/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Health Technology |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale